Search

everythinglearnresearchcommunity

for

Search:↓

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The conclusion suggests using a science-based, multi-targeted treatment for hair loss instead of just biotin.

Mitochondria may influence how cells respond to radiation, affecting nearby non-irradiated cells.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

The new treatment using tiny lipid carriers to deliver minoxidil and latanoprost directly to hair follicles shows promise for alopecia.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

The study created a new method to test drugs that affect hormone processing in skin.

Deleting the EDAR gene in Cashmere goats affects genes and proteins related to hair growth.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

The transfollicular route shows promise for noninvasive, targeted drug delivery but needs more research.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Targeted testing for telogen effluvium patients can save healthcare costs.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

Researchers made a detailed map of gene activity for different parts of human hair follicles to help create targeted hair disorder treatments.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Nanospanlastics are effective in targeted drug delivery for chronic diseases, improving skin conditions, treating hair loss, and increasing drug absorption.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.